VRAYQ (ViewRay) EBIT per Share : $-0.57 (TTM As of Mar. 2023)

View and export this data going back to 2014. Start your Free Trial

What is ViewRay EBIT per Share?

ViewRay's EBIT per Share for the three months ended in Mar. 2023 was $-0.14. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2023 was $-0.57.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for ViewRay's EBIT per Share or its related term are showing as below:

VRAYQ's 3-Year EBIT Growth Rate is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 7.45
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

ViewRay's EBIT for the three months ended in Mar. 2023 was $-26.2 Mil.

ViewRay EBIT per Share Historical Data

The historical data trend for ViewRay's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ViewRay EBIT per Share Chart

ViewRay Annual Data

Trend

Nov13

Nov14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

EBIT per Share

Get a 7-Day Free Trial

-0.85

-1.14

-0.71

-0.64

-0.57

ViewRay Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
EBIT per Share	Get a 7-Day Free Trial															-0.14	-0.15	-0.14	-0.14	-0.14

ViewRay EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

ViewRay's EBIT per Share for the fiscal year that ended in Dec. 2022 is calculated as

	EBIT per Share		(A: Dec. 2022 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-102.273	/	180.697
=	-0.57

ViewRay's EBIT per Share for the quarter that ended in Mar. 2023 is calculated as

	EBIT per Share		(Q: Mar. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-26.233	/	182.311
=	-0.14

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.57

ViewRay (OTCPK:VRAYQ) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

ViewRay EBIT per Share Related Terms

Thank you for viewing the detailed overview of ViewRay's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

ViewRay Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ViewRay Inc (OTCPK:VRAYQ) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

1099 18th Street, Suite 3000, Denver, CO, USA, 80202

Website

https://www.viewray.com

ViewRay Inc is a radiation therapy and imaging technology company. It designs, manufactures, and markets radiation therapy systems that provide real-time imaging during radiation treatment. Its product portfolio encompasses The MRIdian linac system, The MRIdian system, the Monte Carlo treatment planning system, etc. The company holds the license for its combination of MRI and radiation therapy technologies. Geographically, it derives a majority of its revenue from the United States.

Executives

Karen Prange	director	1108 S RIO VISTA BLVD, FORT LAUDERDALE FL 33316
B Kristine Johnson	director	366 FERNDALE RD S, WAYZATA MN 55391
Sanket Shah	officer: SVP, General Counsel	C/O VIEWRAY, INC., 2 THERMO FISHER WAY, OAKWOOD VILLAGE OH 44146
Farhad Fred Ebrahimi	10 percent owner	191 UNIVERSITY BLVD., #246, DENVER CO 80206
Caley Castelein	director	THOM. WEISEL HEALTHCARE VENTURES, ONE MONTGOMERY STREET, SAN FRANCISCO CA 94104
Paul Jr Ziegler	officer: Chief Commercial Officer	C/O VIEWRAY, INC., 2 THERMO FISHER WAY, OAKWOOD VILLAGE OH 44146
Scott William Drake	director, officer: President and CEO	9965 FEDERAL DRIVE, COLORADO SPRINGS CO 80921
Adam Andrew Podbelski	officer: SVP, Customer Services	C/O VIEWRAY, INC., 2 THERMO FISHER WAY, OAKWOOD VILLAGE OH 44146
Jacob Edward Signoriello	officer: Chief Financial Officer	C/O VIEWRAY, INC., 1099 18TH STREET, SUITE 3000, DENVER CO 80202
James F. Dempsey	director, officer: Chief Scientific Officer	C/O VIEWRAY INCORPORATED, 2 THERMO FISHER WAY, OAKWOOD VILLAGE OH 44146
Burke William P. Mr.	officer: Chief Financial Officer	HAEMONETICS CORPORATION, 400 WOOD ROAD, BRAINTREE MA 02184
Susan C Schnabel	director	C/O CREDIT SUISSE FIRST BOSTON, 11 MADISON AVE, NEW YORK NY 10010
Brian K Roberts	director	DIGITAS INC.,, 800 BOYLSTON STREET, BOSTON MA 02199
Zachary William Stassen	officer: Chief Financial Officer	C/O VIEWRAY, INC., 2 THERMO FISHER WAY, OAKWOOD VILLAGE OH 44146
Daniel Jeffrey Moore	director	100 CYBERONICS BVLD, HOUSTON TX 77058